Literature DB >> 7095748

The spectrum of hepatic candidiasis.

J H Lewis, H R Patel, H J Zimmerman.   

Abstract

The liver is affected in up 50 to 75% of compromised hosts with disseminated Candida albicans infection who come to autopsy. The antemortem diagnosis of hepatic candidiasis is rarely made. Blood cultures are negative in approximately 50% of cases, and biochemical parameters of hepatic injury may be of nonspecific value. Additionally, the more commonly seen renal, cardiac, and respiratory involvement may overshadow the hepatic lesion. In a review of 17 autopsy series of disseminated candidiasis, 92 cases with hepatic involvement were identified for a mean prevalence of 13.7%. Hepatic granulomas and microabscesses were the two most common histological lesions attributable to Candida. Inflammatory aggregates, centrilobular congestion, bile stasis, and fatty change were seen less frequently. The diagnosis should be suspected in any compromised host with unexplained fever with or without elevated alkaline phosphatase or bilirubin levels. The diagnosis can be made by percutaneous needle biopsy or at laparoscopy in a majority of cases. Early treatment with Amphotericin is associated with prolonged survival.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7095748     DOI: 10.1002/hep.1840020415

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

Review 1.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 2.  Chronic systemic candidiasis.

Authors:  G P Bodey; E J Anaissie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

3.  Candida albicans liver abscesses.

Authors:  R Finkelstein; C Wichtig; M Hashmonai
Journal:  Infection       Date:  1985 Sep-Oct       Impact factor: 3.553

4.  Evaluation of a murine model of hepatic candidiasis.

Authors:  G T Cole; K T Lynn; K R Seshan
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

5.  Hepatosplenic candidasis, a fatal disease?

Authors:  A Loeliger; M van Leeuwen; M Rozenberg-Arska; A W Dekker
Journal:  Infection       Date:  1992-11       Impact factor: 3.553

6.  Bacterial-mycotic liver abscess in a non-immunocompromised host.

Authors:  J Niebel; U Farack; V Mursic
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

Review 7.  Liver involvement in systemic infection.

Authors:  Masami Minemura; Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Hepatol       Date:  2014-09-27

Review 8.  Cholangitis in the acquired immunodeficiency syndrome: report of two cases and review of the literature.

Authors:  D Roulot; D Valla; F Brun-Vezinet; M A Rey; F Clavel; C Degott; J Guillan; J Verduron; B Rueff; J P Benhamou
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

Review 9.  Mycotic infection and the pediatric surgeon.

Authors:  H Nagar
Journal:  Mycopathologia       Date:  1990-12       Impact factor: 2.574

10.  Hepatosplenic candidiasis, a late manifestation of Candida septicaemia in neutropenic patients with haematologic malignancies.

Authors:  M von Eiff; M Essink; N Roos; W Hiddemann; T Büchner; J van de Loo
Journal:  Blut       Date:  1990-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.